Skip to content

Inflammation in an Ultra Endurance Race

Per Effort Study of Inflammatory Consequences of an Ultra Endurance Race (165km)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03194035
Acronym
TRAIL-INFLA
Enrollment
25
Registered
2017-06-21
Start date
2018-10-01
Completion date
2018-10-17
Last updated
2018-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Inflammatory Response

Keywords

inflammation, exercise, ultra endurance

Brief summary

The aim of this study is to study the per and post-exertional variations of the pro and anti inflammatory markers during an ultra-endurance race in healthy volunteers.

Detailed description

Study per and post-exertional changes in proinflammatory biological (IL1, IL6, TNF alpha, HMG beta1 and CRP) and anti inflammatory parameters (IL4, IL10 and IL13, TGF beta, LPS, lipoproteins, lipids) during an ultra endurance race.

Interventions

BIOLOGICALblood sample

Study per and post-exertional changes in proinflammatory biological (IL1, IL6, TNF alpha, HMG beta1 and CRP) and anti inflammatory parameters (IL4, IL10 and IL13, TGF beta, LPS, lipoproteins, lipids) during an ultra endurance race.

Sponsors

Hôpital Necker-Enfants Malades
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Male older than 18 years, 2. Completion of an ultra-endurance race (distance greater than 50 kilometers) during the 24 months preceding the race. 3. Affiliation or beneficiary of a social security.

Exclusion criteria

1. Age lower than 18 years, 2. Subjects with a medical history (pulmonary pathology, cardiac, hypertension) or with a significant chronic inflammatory disease observed during the inclusion visit (the day before the race). 3. Female.

Design outcomes

Primary

MeasureTime frameDescription
Per and post-exertional variations of IL1 during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of IL1 blood level
Per and post-exertional variations of IL6 during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of IL6 blood level
Per and post-exertional variations of TNF alpha during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of TNF alpha blood level
Per and post-exertional variations of HMG beta during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of HMG beta blood level
Per and post-exertional variations of CRP during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of CRP blood level
Per and post-exertional variations of IL4 during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of IL4 blood level
Per and post-exertional variations of IL10 during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of IL10 blood level
Per and post-exertional variations of IL13 during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of IL13 blood level
Per and post-exertional variations of lipids during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of lipids blood level
Per and post-exertional variations of LPS during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of LPS blood level
Per and post-exertional variations of lipoprotein during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of lipoprotein blood level
Per and post-exertional variations of TGF beta during an ultra-endurance race in healthy volunteers.Change measures : departure, 15, 50, 65, 90, 130 and 165 kilometers then at day 1 and 2 after the completion of the raceIn this study, the investigators will measure variations of TGF beta blood level

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026